Page last updated: 2024-08-24

plerixafor and isoproterenol

plerixafor has been researched along with isoproterenol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Dhume, A; Hadri, L; Hajjar, RJ; Jarrah, AA; LaRocca, T; Schecter, AD; Schwarskopf, M; Tarzami, ST; Wang, ER; Zhang, S1

Reviews

1 review(s) available for plerixafor and isoproterenol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for plerixafor and isoproterenol

ArticleYear
SDF-1 induces TNF-mediated apoptosis in cardiac myocytes.
    Apoptosis : an international journal on programmed cell death, 2018, Volume: 23, Issue:1

    Topics: Animals; Apoptosis; Benzylamines; Caspase 3; Chemokine CXCL12; Cyclams; Dose-Response Relationship, Drug; Doxorubicin; Gene Expression Regulation; Heterocyclic Compounds; Isoproterenol; Mitochondria; Myocytes, Cardiac; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Signal Transduction; Tumor Necrosis Factor-alpha

2018